Pancreatic Cancer Research

ResearcherIRCCS Ospedale San RaffaeleActive in the last 2 years

Martina Mori

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2011-5898; OpenAlex author ID A5046880314. Sources: OpenAlex.

Their work

Papers
7 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 7

  1. Temporal Validation of an FDG-PET-Radiomic Model for Distant-Relapse-Free-Survival After Radio-Chemotherapy for Pancreatic Adenocarcinoma. First author DOI 10.3390/cancers17061036↗
  2. Limited impact of discretization/interpolation parameters on the predictive power of CT radiomic features in a surgical cohort of pancreatic cancer patients. First author DOI 10.1007/s11547-023-01649-y↗
  3. Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC). Co-author DOI 10.1245/s10434-022-11413-7↗
  4. Stomach and duodenum dose-volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in combination with chemotherapy. Co-author DOI 10.3389/fonc.2022.983984↗
  5. Prediction of Early Distant Recurrence in Upfront Resectable Pancreatic Adenocarcinoma: A Multidisciplinary, Machine Learning-Based Approach. First author DOI 10.3390/cancers13194938↗
  6. Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemotherapy for locally advanced pancreatic … Co-author DOI 10.1016/j.radonc.2020.07.003↗
  7. Quantifying the robustness of [18F]FDG-PET/CT radiomic features with respect to tumor delineation in head and neck and pancreatic cancer patients. First author DOI 10.1016/j.ejmp.2018.05.013↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Claudio Fiorino · 7 shared papers, 2018–2025 · strength 0.95
  2. Michele Reni · 5 shared papers, 2020–2025 · strength 0.70
  3. Nadia Gisella Di Muzio · 4 shared papers, 2018–2025 · strength 0.52
  4. Paolo Passoni · 4 shared papers, 2018–2025 · strength 0.52
  5. Massimo Falconi · 3 shared papers, 2021–2023 · strength 0.43
  6. Maria Picchio · 3 shared papers, 2018–2025 · strength 0.38
  7. Sara Broggi · 3 shared papers, 2018–2022 · strength 0.31
  8. Diego Palumbo · 2 shared papers, 2021–2023 · strength 0.28
  9. Francesco DE COBELLI · 2 shared papers, 2021–2023 · strength 0.28
  10. Stefano Crippa · 2 shared papers, 2021–2023 · strength 0.28
  11. Giovanni Mauro Cattaneo · 2 shared papers, 2018–2022 · strength 0.21
  12. M. De Vincenzi · 1 shared paper, 2025 · strength 0.21
  13. Sara Loi · 1 shared paper, 2023 · strength 0.18
  14. Claudio Doglioni · 1 shared paper, 2022 · strength 0.15
  15. Miriam Redegalli · 1 shared paper, 2022 · strength 0.15
  16. Gianpaolo Balzano · 1 shared paper, 2022 · strength 0.15
  17. Maria Giulia Cangi · 1 shared paper, 2022 · strength 0.15
  18. Paolo Giorgio Arcidiacono · 1 shared paper, 2022 · strength 0.15
  19. Marco Schiavo Lena · 1 shared paper, 2022 · strength 0.15
  20. Giulio Belfiori · 1 shared paper, 2021 · strength 0.10
  21. Domenico Tamburrino · 1 shared paper, 2021 · strength 0.10
  22. Stefano Cascinu · 1 shared paper, 2021 · strength 0.10
  23. R. Calandrino · 1 shared paper, 2018 · strength 0.07
  24. Maria Luisa Belli · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.